Pharma VC Funds

Moonshots Capital is a seed-stage venture capital firm founded in 2017, with offices in Los Angeles and Austin. The firm focuses on investing in companies led by extraordinary leaders, particularly those who are military veterans or serial entrepreneurs. The co-founders, Kelly Perdew and Craig Cummings, leverage their extensive military and entrepreneurial experience to provide more than just capital to their portfolio companies, offering strategic guidance, operational support, and a vast network of contacts. Notable investments by Moonshots Capital include Slack, Robinhood, ID.me, and Bitium. The firm has a diverse portfolio that spans various sectors such as fintech, cybersecurity, consumer internet, and web3 technologies. Moonshots Capital takes an active role in the companies they invest in, often taking board seats or formal advisory roles to ensure they can provide maximum support and value. The firm's investment strategy prioritizes companies with strong leadership, a proven track record, and the potential for high growth. Moonshots Capital typically invests in companies that have a product with client traction, monthly recurring revenue of at least $100,000, and have raised at least $500,000 in previous funding rounds. They are particularly interested in companies at the seed or Series A stage that have a clear path to the next round of financing.

Morado Ventures is a venture capital firm focused on seed-stage investments, partnering with passionate entrepreneurs who tackle complex technological problems using both software and hardware solutions. Their current focus areas include Artificial Intelligence, Data Infrastructure, Industrial Internet, Robotics & Autonomy, Computer Vision, and Health. Founded by Ash Patel and Mike Marquez, Morado Ventures brings extensive experience in leading and investing in technology companies. Ash Patel, a former senior executive at Yahoo!, and Mike Marquez, with a background in corporate development at CBS Interactive and Yahoo!, co-founded the firm to leverage their expertise in identifying and nurturing promising startups. Morado Ventures' investment philosophy emphasizes supporting early-stage, data-fueled companies capable of solving significant challenges in industries ripe for disruption. They actively collaborate with founders to develop and execute successful strategies, providing access to a network of seasoned professionals and resources. Their portfolio includes a diverse range of companies such as Lucid Lane, Tensorfield Agriculture, and Cargomatic, reflecting their commitment to fostering innovation across various sectors.

Morningside Group is a venture capital and private equity firm founded in 1986 and headquartered in Newton, Massachusetts. The firm focuses on investing in early-stage companies across various sectors, including biotechnology, consumer electronics, hardware, artificial intelligence, and fintech. Morningside is known for its long-term investment outlook and commitment to supporting innovative and impactful ventures. Notable investments in Morningside's portfolio include Cognoa, Sensel, The Nue Co., Homee, and Prescryptive Health. These investments highlight Morningside's focus on cutting-edge technology and healthcare solutions. The firm has made over 190 investments and has seen more than 30 successful exits, demonstrating its effectiveness in nurturing high-growth companies. Morningside operates globally, with significant investments in the United States and China, and has a diversified portfolio that includes companies like Evonetix in the biotech sector and Wiseconn in agtech. The firm is active in both seed and later-stage investments, providing substantial capital and strategic support to its portfolio companies.

Morningstar Ventures is a Dubai-based venture capital firm founded in 2020 by Danilo Carlucci and Arutyun Nazaryan. The firm focuses on investing in blockchain, digital assets, Web3, and decentralized finance (DeFi). With a portfolio spanning 199 investments, Morningstar has backed notable companies such as Unstoppable Domains and Axelar, both of which have achieved unicorn status. The firm typically participates in early-stage funding, ranging from Seed to Series A rounds, with investments averaging between $1 million to $5 million. Morningstar Ventures stands out for its deep involvement in the growth of its portfolio companies, providing not only capital but also strategic support and access to its vast network in the crypto and blockchain industries. In addition to its investment activities, Morningstar operates MSV GG, an initiative that supports Web3 startups by providing them with industry expertise and marketing resources. This holistic approach allows Morningstar to align closely with the companies it invests in, helping them scale rapidly in the competitive blockchain space. With its headquarters in Dubai, the firm has expanded its influence across various regions, focusing on fostering the next generation of decentralized technologies and contributing to the global adoption of blockchain​.

Morpheus Ventures, founded in 2016 and based in Los Angeles, focuses on early-stage investments in cutting-edge technologies such as data analytics, machine learning, robotics, and SaaS. Their portfolio includes innovative companies like Rigetti Computing, Vicarious, and Starship Technologies. The firm has made significant exits including Rigetti Computing and Vicarious (acquired by Alphabet). Other notable investments include HouseCanary, a real estate data analytics company, SafetyCulture, a leading safety and quality inspection software, and Sidecar Health, a health insurance platform. The leadership team at Morpheus Ventures includes experienced investors like Damien Petty, who has a background in artificial intelligence, robotics, and quantum computing, and has led investments in companies like DeepMind (acquired by Google) and Skype (acquired by Microsoft). The team focuses on identifying and nurturing companies with the potential to disrupt their respective industries and drive significant advancements in technology.

MTN Group is a leading telecommunications company based in Johannesburg, South Africa. The company has a strong presence across Africa and the Middle East, serving over 289 million subscribers. MTN Group's investment arm has made notable investments in sectors such as telecom infrastructure, renewable energy technology, and horizontal e-commerce. Key investments include companies like Fenix International, a renewable energy company acquired by ENGIE, and Jumia, a leading e-commerce platform in Africa. Another significant investment is in IHS Towers, one of the largest independent owners, operators, and developers of shared telecommunications infrastructure. MTN Group has committed substantial funds towards infrastructure projects to enhance its service delivery. For instance, it pledged $215 million for infrastructure investment in Benin over three years, focusing on building a state-of-the-art office for MTN Benin and expanding digital solutions across the region. Financially, MTN Group has reported strong performance with a 23.4% return on equity and a 10% increase in dividends to 330 cents per share. The group's strategic focus includes expanding its fintech ecosystem, investing in network infrastructure, and promoting digital inclusion across its markets.

Moving Capital, now known as Karman Ventures, is a venture capital firm founded by Uber alumni to support startups with innovative solutions. The firm has made notable investments across various sectors, including aerospace, artificial intelligence, retail technology, and green technology. Noteworthy investments by Karman Ventures include Whisper Aero, a company focusing on aerospace and green technology; Luca, which specializes in AI-driven retail technology; and Regent, which develops electric vehicles for marine transportation. Other significant investments are in companies like Gigs, focusing on mobile applications, and Kasa Living, a hospitality tech company. Karman Ventures is based in Austin, Texas, and has a strong network of co-investors, including prominent firms like Y Combinator, Menlo Ventures, and LaunchTN. Their investment strategy typically involves supporting companies from seed to growth stages, emphasizing scalable and transformative technologies.

Moxxie Ventures is a venture capital firm founded in 2019 by Katie Jacobs Stanton, a former Twitter executive and co-founder of the #ANGELS investment collective. The firm is based in Mountain View, California, with a secondary office in Boulder, Colorado. Moxxie Ventures focuses on early-stage investments, particularly in consumer, enterprise, fintech, healthtech, and climate sectors. Moxxie Ventures recently closed its second fund at $85 million, a significant increase from its inaugural $25 million fund. The firm typically writes checks ranging from $250,000 to $500,000 and aims to make 10 to 12 investments per year, reserving half of the fund for follow-on investments. Notable investors backing Moxxie Ventures include Bain Capital Ventures, Bloomberg Beta, Foundry Group, and individual investors such as Marc Andreessen, Susan Wojcicki, and Jerry Yang. The firm prides itself on bringing a combination of capital, operating experience, and a strong network to its portfolio companies. Stanton and her team leverage their extensive backgrounds in product, engineering, marketing, and business development to support founders in scaling their businesses. Moxxie Ventures is committed to partnering with founders who are passionate about making life and work better through innovative solutions. Some of their notable investments include companies like Elpha, Carta, and Clubhouse. The firm continues to build on its mission to support founders with not just funding but also strategic guidance and connections to a broad network of industry experts and leaders.

MPM Capital, founded in 1997, is a leading venture capital firm based in Boston and San Francisco, specializing in biotechnology and life sciences investments. The firm has a robust portfolio, having invested in over 150 companies, including notable names like 23andMe, ReNAgade Therapeutics, and Argenx. MPM Capital's focus is on transforming innovative scientific discoveries into breakthrough medicines, particularly in oncology and other high-need therapeutic areas​. MPM Capital recently raised $850 million for its second Oncology Impact Fund, marking it as one of the largest biotech impact investment funds globally. This fund emphasizes investments in companies developing novel cancer therapies, reflecting MPM's deep commitment to addressing significant medical challenges. The firm's team includes seasoned professionals with extensive experience in research, drug development, and corporate strategy. Key team members like Dr. Luke Evnin and Dr. Ansbert Gadicke bring invaluable expertise to the firm, guiding its strategic investments and supporting portfolio companies through various growth stages​ .

Mubadala Capital’s Ventures platform stands out as a leading global investor, blending the strengths of Mubadala Investment Company with the agility of a venture capital firm. Focused on technology and healthcare sectors, Mubadala has made over 75 investments, including notable startups like Chroma Medicine, Recursion Pharmaceuticals, and Exscientia. Their strategy revolves around partnering with visionary founders to build enduring companies, leveraging Mubadala’s extensive resources and global scale. Geographically, Mubadala Ventures operates with a significant presence in technology hubs such as San Francisco, London, and Abu Dhabi, ensuring deep integration into the global innovation ecosystem. They emphasize Series A+ investments in the U.S. and Series B+ in Europe, providing substantial capital and strategic support to their portfolio companies. Mubadala's investment strategy is marked by a focus on capital preservation and downside protection, ensuring sustainable growth and returns. The fund typically invests in founder-led companies, with average check sizes tailored to the needs of each growth stage. They are known for their disciplined approach to evaluating opportunities, benefiting from Mubadala's broad network and sovereign backing. The team at Mubadala Ventures includes industry veterans like Ibrahim Ajami, Head of Ventures, and Alaa Halawa, Co-Head of US Ventures. Their expertise spans various sectors and geographies, further strengthening Mubadala’s investment acumen. Startups looking to engage with Mubadala are advised to highlight their alignment with Mubadala’s strategic focus and demonstrate robust business models that can benefit from Mubadala’s vast resources and network.

Mucker Capital, founded in 2012 and headquartered in Los Angeles, is a venture capital firm that invests in seed and early-stage startups across the United States, Canada, and beyond. With additional offices in Austin and Toronto, Mucker Capital focuses on internet-enabled software and services, aiming to support startups outside the traditional Silicon Valley ecosystem. The firm believes that great companies can be built anywhere and provides tactical help, networking opportunities, and a bridge to Silicon Valley resources. Notable portfolio companies include Honey, acquired by PayPal; Surf Air, which went public on NASDAQ; and ServiceTitan, a business management software for home service providers. Mucker Capital has also backed companies like The Black Tux, ServiceTitan, and BloomNation. MuckerLab, their pre-seed accelerator, is highly regarded and ranked second in the U.S. by the Seed Accelerator Rankings Project based on valuations, exits, fundraising, survival, and founder satisfaction. Mucker Capital's approach includes rolling up their sleeves to work alongside entrepreneurs on product development, marketing, sales, recruiting, and other critical areas to help startups succeed. The firm has launched multiple funds, including Mucker III, a $45 million seed-stage fund, and continues to support the growth and scaling of innovative startups.

Muse Capital is an early-stage venture capital fund based in Los Angeles, California, focused on investing in consumer-facing startups. Founded in 2016, the firm aims to bridge the gap between Silicon Valley, the entertainment industry, and the corporate sector, providing strategic capital and partnership-based business development. Muse Capital has a diverse portfolio that includes companies like CoFertility, Beekeeper's Naturals, Cloud Paper, and Firefly, all of which are pushing boundaries in telehealth, education, motherhood, gaming, and underserved markets. The firm is led by Assia Grazioli-Venier and Rachel Springate, who leverage their extensive networks in the entertainment and corporate worlds to support their portfolio companies. Muse Capital typically invests in seed-stage rounds, providing both financial backing and strategic guidance to help startups grow and succeed. Muse Capital is particularly known for its active involvement in the companies it invests in, offering tactical insights and connections to key industry players. This hands-on approach has made Muse a valuable partner for entrepreneurs looking to disrupt and innovate within the consumer sector. For startups looking to engage with Muse Capital, demonstrating a clear vision for consumer impact and leveraging the firm’s entertainment and corporate connections can be crucial.

Musa Ventures is a cutting-edge platform dedicated to improving the funding readiness of startups and small to medium businesses (SMBs). They leverage advanced analytics, artificial intelligence, and machine learning to deliver comprehensive venture health assessments. This holistic approach goes beyond financial metrics, providing founders with detailed insights into their ventures' strengths and areas needing improvement. The platform offers intelligent venture health dashboards that give real-time feedback and actionable recommendations. These dashboards are designed to help founders understand strategic gaps and enhance their appeal to potential funders. By offering objective feedback and insights from experienced advisors, Musa Ventures aims to make the fundraising process more transparent and accessible. Musa Ventures also employs proprietary assessment tools developed from over 30 years of global experience and research into ventures and SMBs. These tools analyze data from more than 20,000 ventures and involve input from over 600 funding firms, ensuring a robust and reliable evaluation process. In addition to assessments, Musa Ventures uses algorithmic matching to connect funding-ready ventures with suitable funders or partners. This approach helps streamline the funding process, making it easier for businesses to secure the right type of funding from the right sources. Musa Ventures thus plays a pivotal role in fostering a symbiotic relationship between startups and financial backers, ultimately contributing to healthier and more successful business ventures.

MVM Partners, founded in 1997, is a global venture capital firm focused on high-growth healthcare investments. With offices in Boston and London, MVM invests broadly across sectors including medical technology, pharmaceuticals, diagnostics, digital health, and other healthcare-related fields. Their portfolio includes notable companies such as SkyCell, which developed patented temperature-control technology for safely transporting vaccines and biotech drugs, and Ossio, which created OSSIOfiber Intelligent Bone Regeneration Technology—a novel orthopedic fixation material that integrates into native bone and avoids the need for permanent metal implants. MVM also invested in MDxHealth, a company specializing in molecular diagnostics for urologic cancers, which enhances personalized cancer diagnosis and treatment. MVM's investment strategy emphasizes significant minority stakes in innovative companies, providing both financial support and strategic guidance to help these companies grow and scale. Their approach involves close collaboration with management teams to drive business development and market expansion. MVM's recent investments include companies like eXmoor Pharma, which focuses on cell and gene therapy services, and Nalu Medical, which develops minimally invasive solutions for chronic pain management. These investments reflect MVM's commitment to supporting advancements in medical technology and improving patient outcomes globally.

My Climate Journey Collective (MCJ Collective) is a venture capital firm dedicated to investing in innovative climate solutions. Founded to drive significant impact in combating climate change, MCJ Collective supports early-stage startups across a range of sectors including renewable energy, mobility, food systems, and sustainable infrastructure. MCJ Collective's portfolio includes notable companies such as BlocPower, which focuses on clean energy and smart city solutions, and Arcadia, a technology company democratizing access to clean energy. They have also invested in Enode, a developer of APIs for information services, and Hoxton Farms, a biotechnology company working on sustainable food solutions. The firm is known for its broad investment strategy, backing startups that aim to mitigate climate change and improve environmental sustainability. They have a strong focus on sectors like renewable energy, electrification, carbon management, and the built environment. MCJ Collective emphasizes the importance of technological innovation in addressing climate challenges, supporting companies that leverage AI, data centers, and other advanced technologies. The team at MCJ Collective includes experienced professionals with a deep understanding of climate issues and investment strategies, ensuring that they provide not only capital but also strategic guidance to their portfolio companies. For more detailed information, you can explore their portfolio and insights on their official.

Mystic Ventures, founded in 2021 and based in Los Angeles, is a venture capital firm focused on the rapidly growing psychedelic medicine and mental health sector. The fund is committed to advancing research and developing innovative treatments using psychedelics to address conditions like depression, anxiety, PTSD, and other mental health issues. Mystic Ventures typically invests in pre-seed and seed-stage companies that are pioneering these therapies. Led by Jeremy Gardner and Brock Pierce, the firm takes a biotech-oriented approach, partnering with scientific research teams and pharmaceutical experts to bring cost-effective, holistic psychedelic solutions to the mainstream. With a rolling fund structure on AngelList, Mystic Ventures is uniquely positioned to offer flexible capital to startups, supporting their long-term growth in the burgeoning field of psychedelic therapeutics. The fund has backed companies like Psylo and Heading Health, among others. By investing in breakthrough treatments that go beyond traditional pharmaceutical approaches, Mystic Ventures aims to reshape how mental health treatments are developed and accessed, while offering investors exposure to this transformative market.

Nama Ventures is a seed-stage venture capital fund based in Riyadh, Saudi Arabia, focused on fueling innovation across the MENA region, particularly in Saudi Arabia. Founded by Mohammed Alzubi, the fund is committed to nurturing early-stage technology startups with a strong emphasis on team-based ventures over solo founders. Their portfolio includes notable investments like PIESHIP in logistics, palm.hr in business productivity software, and Brev.dev, an AI and ML platform recently acquired by NVIDIA. Nama Ventures emphasizes supporting startups from pre-seed to seed stages, often leading funding rounds and providing strategic guidance to help ventures grow and realize their potential. They have invested in 47 companies, achieving several successful exits, including the acquisition of Brev.dev by NVIDIA. The fund recently launched a $27 million fund to further invest in MENA startups, with some allocations for Silicon Valley-based ventures through strategic syndication partners. Nama Ventures' investment strategy is centered around fostering technology innovation and supporting startups with complementary skill sets in their founding teams. For startups looking to approach Nama Ventures, it's crucial to demonstrate a robust team dynamic, innovative technology, and the potential for significant impact and growth within the targeted markets. The leadership team, including Mohammed Alzubi, brings extensive experience from Silicon Valley, offering a wealth of knowledge and a strong network to support portfolio companies in achieving their goals and scaling their businesses effectively.

Navigare Ventures, founded in 2021 and based in Stockholm, is an early-stage venture capital firm specializing in science-driven companies. As a subsidiary of Wallenberg Investments AB, Navigare Ventures focuses on deep tech sectors, including advanced computing, quantum technologies, synthetic biology, bio innovation, and data-driven life sciences. The firm is committed to investing in transformative technologies that have a strong industrial and societal impact. Navigare Ventures typically invests in Seed and Series A rounds, partnering closely with founders to support the growth and development of their companies. The firm has a robust portfolio that includes companies like Elypta, a startup developing metabolism-based liquid biopsy technology for cancer detection, and EnginZyme, which focuses on sustainable biomanufacturing. Their investment strategy is characterized by long-term partnerships, leveraging an extensive network of scientific and industrial expertise to help startups scale and succeed in their respective fields​.

Necessary Ventures is a San Francisco-based venture capital firm focused on investing in early-stage companies that address significant societal needs. The firm is led by Neil Devani, who brings extensive experience in both venture capital and entrepreneurship. Necessary Ventures primarily invests in companies across a range of sectors including health tech, financial services, biotechnology, and sustainability. Notable investments in their portfolio include Recursion Pharmaceuticals, a company revolutionizing drug discovery through advanced computational methods; Rubi Laboratories, which converts CO2 into sustainable textiles; and Andela, a tech talent training and employment platform. Additionally, they have backed Vicarious Surgical, which develops minimally invasive robotic surgery technology, and Wayve, an AI-driven autonomous vehicle company. The firm is known for its hands-on approach, providing not just capital but also strategic guidance and support to help their portfolio companies scale and succeed. They emphasize a collaborative and empathetic partnership with founders, aiming to create long-term value and impact. Necessary Ventures has a strong presence in both the U.S. and international markets, with investments in various high-growth regions. They have co-invested with leading venture funds such as Y Combinator, Collaborative Fund, and Talis Capital, highlighting their integration into a robust network of investors.

Neo is a venture capital firm based in San Francisco, founded by Ali Partovi, with a strong emphasis on supporting the next generation of tech leaders. Launched in 2012, Neo invests primarily in early-stage startups, often serving as the first institutional investor for many high-growth companies. Neo focuses on industries like AI, consumer internet, and education, investing in startups that have the potential to drive significant innovation. Neo’s investment strategy is centered on a hands-on approach, offering both financial backing and access to a powerful network of industry leaders. With check sizes ranging from $100K to $5 million, Neo supports startups from seed through Series A stages. They also place a high value on mentorship, connecting founders with an elite community of experienced entrepreneurs, engineers, and executives who offer guidance throughout the startup journey. The firm's portfolio includes some of the most promising startups in the tech space, such as Gusto, Pachama, and Notion. Neo prides itself on fostering diversity and inclusion, believing that the best tech companies are built by teams from a variety of backgrounds. Led by Ali Partovi and supported by a team of seasoned investors and operators, Neo is committed to making a long-term impact in the startup ecosystem by focusing on companies that combine technological innovation with meaningful social impact.

Neotribe Ventures, founded in 2017 and based in Menlo Park, California, is a venture capital firm that focuses on investing in breakthrough technologies across various sectors including applied artificial intelligence, biotech, enterprise infrastructure, and the internet of things. The firm targets early to growth-stage companies that are shaping the future through innovative solutions. Neotribe Ventures has made 98 investments with notable companies in its portfolio such as Energy Vault, Heliogen, and CipherTrace. The firm has achieved 17 exits, including significant companies like Robinhood, which went public in July 2021. Other successful exits include Pluribus Networks and ClearMotion. The firm is led by co-founders Swaroop Kolluri and Steven Bragonier, along with partners like Nitin Chopra and Neeraj Hablani. Neotribe Ventures manages nearly $450 million in assets across three funds, including the recent Ignite Fund, which focuses on growth-stage investments. Neotribe Ventures' strategy involves providing not just capital but also extensive support and resources to help their portfolio companies succeed. The firm's emphasis on deep technology and innovative solutions makes it a significant player in the venture capital landscape​.

Neulogy Ventures, established in 2014 and based in Bratislava, Slovakia, is a Luxembourg-regulated venture capital fund. The firm focuses on early-stage tech companies, particularly those operating in Slovakia and the Central and Eastern Europe (CEE) region. Neulogy Ventures manages €65 million in assets, with a diverse portfolio spread across 10 countries. The fund targets investments in sectors like media, cleantech, data analytics, productivity applications, medtech, infrastructure, fintech, security, 3D, e-commerce, and new energy. Neulogy Ventures aims to support mission-driven entrepreneurs with bold ideas that push technological frontiers, particularly those addressing climate change and healthcare challenges. Neulogy Ventures emphasizes a hands-on approach, offering strategic guidance, business development support, and fundraising assistance to its portfolio companies. The firm values long-term partnerships, prioritizing shared values and a collaborative approach over quick exits. Notable companies in Neulogy's portfolio include GA Drilling, GreenWay, and GroupSolver. The team, led by managing partners Christian Mandl and Jaroslav Luptak, brings extensive experience in entrepreneurship, fundraising, and business development, ensuring robust support for their investees.

New Age Capital, founded in 2016 by Ivan Alo and LaDante McMillon, is a New York-based venture capital firm focusing on seed-stage investments in tech and tech-enabled startups led by Black and Latino entrepreneurs. The firm aims to bridge the funding gap for underrepresented founders by providing not only capital but also strategic guidance and access to a robust network of investors and partners. The firm typically invests between $850,000 and $1 million per company, targeting an ownership stake of 10-15%. New Age Capital prefers to lead funding rounds and maintains a hands-on approach, fostering long-term relationships with founders well in advance of their capital needs. This strategy allows the firm to provide tangible value and support through various growth stages. New Age Capital's portfolio includes a diverse array of companies such as Myavana, a personalized hair care recommendation platform; PredictionStrike, a sports stock market; and Navigate Maternity, which uses data to support prenatal and postpartum care. The firm's emphasis on authenticity, empathy, and transparency has positioned it as a trusted partner for founders from historically underfunded communities. By focusing on capital-efficient, high-potential startups in large and fragmented markets, New Age Capital aims to generate outsized returns while driving significant impact in the entrepreneurial ecosystem.

New Enterprise Associates (NEA) is a global venture capital firm with a storied history of supporting innovative businesses. Founded in 1977, NEA manages over $25 billion in assets and invests across all stages of a company's lifecycle, from seed stage to IPO. The firm has a diverse portfolio that spans technology and healthcare sectors. NEA's notable investments include companies like 23andMe, Coursera, Robinhood, and Uber, highlighting their focus on transformational businesses. They have facilitated over 270 IPOs and more than 450 mergers and acquisitions, underscoring their impact on the market. The firm operates from key locations in Menlo Park, California, and New York City, but their investment reach is global, covering North America, Europe, Asia, and beyond. NEA's strategy involves not just funding but also actively mentoring and supporting their portfolio companies through various stages of growth. Recently, NEA closed on two new funds totaling $6.2 billion, the largest in the firm's history, aimed at early-stage and growth-stage investments in sectors like enterprise tech, fintech, digital health, and life sciences. This reflects NEA’s commitment to driving innovation and supporting founders with the capital and expertise needed to build successful companies.

NLV Partners, founded in 2005, is a leading venture capital firm focused on revolutionizing healthcare. With notable investments in companies like CRISPR Therapeutics, Akili Interactive Labs, and iRhythm Technologies, NLV Partners targets biopharmaceuticals, diagnostics, medical devices, and healthcare IT. Their portfolio boasts 30 billion-dollar companies and numerous successful exits, reflecting their impact in the industry. Geographically, NLV Partners concentrates on the United States, partnering with businesses from startup stages to public offerings. Their investment strategy involves backing visionary teams and disruptive healthcare technologies. They aim to develop commercially attractive and clinically important healthcare solutions, leveraging decades of experience and deep domain expertise to navigate the complex healthcare landscape. NLV Partners typically leads investment rounds, providing not only capital but also strategic guidance. They prefer to be approached through well-prepared pitches that clearly demonstrate the potential for clinical and commercial success. The fund's average check size varies, tailored to the needs of each investment. The team includes co-founders Ron Hunt and Vijay Lathi, based in New York and Menlo Park respectively. Both bring extensive experience in healthcare investments and have been instrumental in shaping the firm's strategic direction. For startups seeking a partner with profound industry knowledge and a track record of success, NLV Partners stands out as a pivotal ally in the healthcare sector.

VisVires New Protein, recently rebranded as Clay Capital, is a Singapore-based venture capital firm dedicated to transformative investments in the agrifood tech sector. Founded in 2014, Clay Capital focuses on supporting innovative startups that address fundamental challenges in the food system, particularly in the areas of sustainable packaging, fermentation, agricultural biologicals, crop disease resistance, soil health, and regenerative agriculture. Notable investments include French biostimulant producer Toopi, Israeli bioherbicide startup WeedOUT, and French kitchen robot manufacturer Cook-e. These investments reflect Clay Capital's commitment to leveraging technology to improve sustainability and efficiency in the food and agriculture sectors. Clay Capital's strategy involves investing in early-stage to growth-stage startups, typically with initial checks ranging from $3 million to $8 million, and reserving additional capital for follow-on investments. The firm serves as a bridge between the Asian and European markets, providing startups with support to access and expand in these regions. The rebranding from VisVires New Protein to Clay Capital signifies a renewed focus on building a healthy and sustainable food system, symbolizing fertile ground for growth and innovation. With a newly raised $145 million fund, Clay Capital is well-positioned to continue driving impactful changes in the agrifood tech landscape

New Science Ventures (NSV) is a premier venture capital firm established in 2004, with offices in New York and London. The firm specializes in investing in companies that leverage groundbreaking scientific innovations in the life sciences and information technology sectors. NSV has a keen focus on businesses with strong IP protection and those addressing significant unmet market needs. Notable investments include Ventyx Biosciences, Phase Four, Achronix Semiconductor, and Paragraf. NSV is particularly interested in companies that can transform their industries with innovative scientific approaches. Their strategy is to invest in both early and mid-stage companies, supporting them through crucial growth phases to maximize their potential and value. NSV is not afraid to take contrarian views and often seeks opportunities outside traditional tech hubs, emphasizing the importance of science-based innovation. The firm typically leads funding rounds and provides substantial follow-on support, ensuring that their portfolio companies have the resources needed to succeed. Key team members include co-founder Tom Lavin, who brings over 30 years of experience in finance and investment banking, and Raju Mohan, a seasoned biotech entrepreneur and senior advisor with extensive expertise in drug discovery and development. Startups looking to engage with NSV should emphasize their scientific uniqueness and potential for significant market impact. NSV values strong management teams and clear, defensible IP strategies, making these essential points of focus when approaching the firm.

NewSpring Capital, founded in 1999 and headquartered in Radnor, Pennsylvania, is a private equity firm focusing on growth equity, mezzanine capital, healthcare, and buyouts. The firm manages approximately $3.5 billion in assets and has invested in over 250 companies across various sectors. Notable investments in NewSpring's portfolio include Vacasa, a leading vacation rental management company; Innovid, a video marketing platform; and Nutrisystem, a weight management company. These investments reflect NewSpring's strategy of supporting high-growth companies in business services, healthcare, information technology, and consumer products. NewSpring Capital operates through multiple strategies, including NewSpring Growth, which targets high-growth technology companies; NewSpring Healthcare, focusing on innovative healthcare services and technology; and NewSpring Mezzanine, providing capital for acquisitions and recapitalizations. The firm's comprehensive approach allows them to support companies at different stages of their lifecycle, from early growth to expansion.

New Stack Ventures is an early-stage venture capital firm focused on investing in founders who are often overlooked by traditional venture capital firms. Founded by Nick Moran, New Stack Ventures targets startups in under-capitalized markets and geographies, with a particular focus on IoT, deep tech, smart hardware, and various platform-based business models. The firm recently closed its second fund, New Stack Ventures Fund II, at $42.6 million, significantly larger than its first $6 million fund. This new fund allows New Stack to support an additional 35 companies at the pre-seed and seed stages. The firm prides itself on being one of the largest single-partner funds raised outside of the typical Silicon Valley ecosystem, emphasizing its commitment to backing "outsider" founders. New Stack Ventures has built a strong reputation for its proactive and founder-friendly approach. The firm was highlighted by TechCrunch as one of the most active and engaged investors in the industry. Its portfolio includes notable companies like Draftbit, Curv, and Flamingo, reflecting its diverse investment strategy. The team at New Stack Ventures is comprised of experienced professionals, including Nate Pierotti, Luke Skertich, and Ariella Frank, who bring extensive backgrounds in startups, product management, and venture capital. Their collaborative and inclusive investment process ensures they identify and support high-potential startups effectively.

New York Angels, founded in 2004, is one of the most active and well-established angel investor groups based in New York City. Specializing in early-stage investments, the group has made over 386 investments, with notable successes including Greenhouse Software, Payoneer, and Billtrust. Their portfolio spans various sectors such as Artificial Intelligence, Fintech, Healthcare, and SaaS. New York Angels typically invests in increments starting from $25,000 and expects its members to invest a minimum of $50,000 annually in its deals. Their average investment round size is around $2 million, and they are known for both leading and participating in follow-on rounds. The group has achieved 72 exits, indicating a strong track record of identifying and nurturing high-potential startups. The investment strategy of New York Angels emphasizes thorough due diligence and a collaborative approach, leveraging the diverse expertise of its members. They actively engage with their portfolio companies, providing not only capital but also valuable mentorship and networking opportunities. Key figures in the organization include founder David S. Rose, who has played a pivotal role in shaping the group's investment philosophy and operations. Startups looking to secure funding from New York Angels should be prepared to demonstrate strong business fundamentals and a clear growth trajectory

New York Venture Partners, founded in 2014, is a venture capital firm based in New York City. NYVP focuses on early-stage investments, particularly in seed rounds, and aims to support startups with both capital and strategic guidance. The firm has a diverse portfolio with investments across various industries, including enterprise software, cybersecurity, AI, fintech, and health tech. NYVP is known for its notable investments in companies like VHX, Food52, and CrowdTwist, which have achieved significant market success. The firm typically invests check sizes ranging from $300,000 to $700,000, allowing it to support startups through critical early development phases. NYVP's investment strategy emphasizes partnering with innovative entrepreneurs and providing them with resources beyond just financial support. This includes access to experienced advisors who can offer strategic guidance, as well as operational support to help with recruiting and fundraising efforts.

Newark Venture Partners is a seed-stage venture capital firm based in Newark, New Jersey, with a strong focus on B2B software companies. Founded in 2015, NVP aims to support innovative startups by providing seed funding and operational support to foster growth and success. The firm has raised approximately $90 million for its second fund, doubling the size of its first fund. NVP's investment strategy revolves around healthcare, fintech, and supply chain sectors, seeking startups that offer transformative solutions in these high-stakes industries. The firm’s portfolio includes notable companies like Podsights, Optimal Dynamics, and Handspring Health, highlighting their commitment to driving innovation in enterprise software. The team at NVP is led by Managing Partners Tom Wisniewski, Dan Borok, and Vaughn Crowe, who bring extensive experience in venture capital and entrepreneurship. The firm is known for its active involvement in the Newark community, including partnerships with organizations like the Boys and Girls Club of Newark and Braven, which support local talent and promote educational and employment opportunities.

Newfund Capital, founded in 2008, is an entrepreneurial venture capital firm with a strong presence in both Paris and Silicon Valley. With $300 million in assets under management, Newfund focuses on seed-stage startups driving global change. Notable investments include Aircall, Fairmoney, and In2Bones, showcasing their diverse and impactful portfolio. The firm invests primarily in technology, precision medicine, personalized treatment, and brain tech sectors. They emphasize early-stage investments, aiming to support startups from the seed stage through international expansion, particularly in France and North America. Newfund's strategy involves quick decision-making, often providing term sheets within three weeks. They seek entrepreneurs with a global mindset and provide significant value beyond capital, including scaling opportunities, networking, and strategic support. The average check size varies but is tailored to meet the needs of each startup, with Newfund often leading the investment rounds. The team includes key members like Henri Deshays and Patrick Malka, who bring extensive entrepreneurial and investment experience. The team is split between their Paris and Palo Alto offices, allowing them to maintain a strong presence in both Europe and the U.S. For startups looking to scale rapidly with a partner who understands the entrepreneurial journey, Newfund Capital offers a compelling blend of expertise, resources, and strategic guidance.

Newpath Partners is a Boston-based venture capital firm specializing in life sciences. Founded in 2018 by Dr. Thomas Cahill, Newpath focuses on building biotechnology companies from the ground up, partnering with leading academic scientists to translate groundbreaking scientific discoveries into transformative therapies. With a strong commitment to high-impact ventures, the firm is particularly known for its deep involvement in the early stages of company formation, often acting as a founding investor. Newpath Partners manages multiple funds, with its second fund, raised in 2021, amounting to $350 million. This fund continues Newpath’s mission to back companies with high scientific originality and ambitious goals, particularly in areas like regenerative medicine, genomics, and oncology. The firm typically invests in early-stage ventures, providing not only capital but also strategic guidance and access to a network of industry leaders. Dr. Cahill, who also founded the nonprofit Scientists to Stop COVID-19, leads a team that is highly experienced in both science and business, ensuring that the companies they back are well-positioned to make a significant impact in the life sciences arena. Newpath’s approach is characterized by a close collaboration with founders, aligning interests across scientists, investors, and management teams to drive innovation and success.

Newton Biocapital is a Brussels-based venture capital firm with a strong presence in both Europe and Japan, focusing exclusively on the life sciences sector. Established in 2017, the firm’s investment strategy is centered on supporting companies that tackle chronic diseases, with an emphasis on oncology, metabolic diseases, and neurological conditions. Newton Biocapital plays a hands-on role in its portfolio companies, often leading funding rounds and taking board positions to guide scientific and clinical strategies​. The firm manages two funds—Newton Biocapital I (€114M) and Newton Biocapital II, which is currently targeting €150M. NBC I invested in 14 companies across Europe and Japan, including university spin-offs like Epics Therapeutics and ChromaCure in Belgium, and biotech firms like EditForce in Japan. Newton's approach is deeply integrated with the local ecosystems in both regions, leveraging their strong ties to academic institutions, industry experts, and international investors to facilitate cross-border growth and exits​. Newton’s team combines scientific, regulatory, and investment expertise, led by CEO Alain Parthoens. With offices in Brussels and Tokyo, they are uniquely positioned to bridge the innovation pipeline between Europe and Japan, driving impactful advancements in life sciences​.

NewTribe Capital is a Dubai-based venture capital firm primarily investing in early-stage Web3, blockchain, and AI startups. With a portfolio exceeding 200 projects globally, including sectors like DeFi, gaming, infrastructure, and NFTs, NewTribe actively fosters innovation in the digital space. Some notable investments include Cookie3 and KIP, with an average check size around $200,000. The firm focuses on building long-term partnerships, often providing advisory services such as market-making, growth hacking, and smart contract auditing, to ensure the success of its portfolio companies​. Geographically, NewTribe targets the MENA region, but also extends investments into Europe, Asia, and beyond. Its strategy emphasizes infrastructure development that bridges Web2 and Web3, alongside token-based and equity investments. Notably, NewTribe backs projects aligning with Dubai’s Web3 initiatives, offering support through accelerator programs and partnerships. Led by partners such as Dhaval Parikh and Juliet Su, NewTribe’s team combines technical expertise with deep industry connections. For startups seeking funding, NewTribe looks for founders with strong visions in blockchain or AI, particularly those aiming to create large-scale digital infrastructure.

Next 10 Ventures, founded in 2018 by former YouTube executive Ben Grubbs, is a venture firm dedicated to the global creator economy. Headquartered in Los Angeles and Singapore, the firm focuses on early-stage investments and incubation of businesses within the digital content space. With a $50 million fund, Next 10 Ventures supports startups that offer tools and services for content creators, such as GoMeta, which helps design interactive experiences, and SuperBam, a digital rights management firm. The firm’s average investments range from $250,000 to $500,000. Next 10 Ventures specializes in creator-driven businesses in areas like education, entertainment, and entrepreneurial ventures. Their investment strategy targets creators looking for long-term growth, avoiding short-term "money-grab" opportunities. The firm also provides substantial operational support, including crafting business models for creators, many of whom lack formal plans. The team, including hires like Lauren Schnipper, formerly of Facebook, is spread across key creative hubs like Los Angeles and Singapore, with plans to scale in regions with high creator activity. The firm looks for creators who fit into categories such as artists, entrepreneurs, and educators, while prioritizing sustainability and community impact​.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

Next47, the global venture capital arm of Siemens, focuses on investing in early and expansion-stage enterprise tech startups. With a presence in Palo Alto, Berlin, Tel Aviv, London, Munich, and Paris, Next47 specializes in sectors like SaaS, AI, and enterprise technology. Their portfolio boasts notable companies such as Verkada, Skydio, and ChargePoint, reflecting their expertise in backing high-potential tech ventures. Next47's investment strategy emphasizes deep engagement with portfolio companies, providing strategic advice, connections, and resources to help them scale. They lead funding rounds with average check sizes varying based on the stage and requirements of the startup. The firm prides itself on a long-term partnership approach, ensuring consistent support through every growth phase. The fund is highly active, with a robust network of 250+ customers across 15 countries, enabling startups to accelerate their go-to-market strategies and secure significant bookings. Founders benefit from Next47's extensive talent network, assisting in making critical hires and developing executive recruiting strategies. Key team members include Lak Ananth, CEO and Managing Partner, and T.J. Rylander, General Partner, both based in Palo Alto. Their combined experience in venture capital and enterprise tech provides invaluable guidance to startups navigating complex growth trajectories. Next47’s global reach and strategic focus make it a vital player in the enterprise tech venture capital landscape, committed to driving innovation and supporting founders in building the next generation of category-leading companies.

NextGen Venture Partners is a unique venture capital firm that leverages a network-driven approach to investing. Founded in 2012 and based in Baltimore, Maryland, the firm collaborates with over 1,800 Venture Partners to support early-stage and growth-stage companies across various industries in the US​. NextGen typically invests between $1 million to $2 million in seed-stage companies and $3 million to $5 million in growth-stage companies that have $10 million+ in revenue. Their network of Venture Partners, consisting of top entrepreneurs and executives, provides startups with valuable connectivity for sales, hiring, and financing introductions, as well as on-demand advice. The firm's leadership team includes Managing Partners Jon Bassett, Ben Bayat, Brett Gibson, and Chris Keller, along with other experienced professionals like Deborah Chu (Principal) and Corinne Smeriglio (Director of Operations)​. This team brings decades of combined experience in investing and building companies.

NextView Ventures is a venture capital firm specializing in seed-stage investments, focusing on companies that use technology to drive the "Everyday Economy." This includes sectors where people spend significant time, money, and attention. The firm was established in 2011 and operates out of Boston and New York City, with a commitment to backing companies from the concept stage. Notable investments by NextView Ventures include companies such as ThredUp, WHOOP, Attentive, Grove Collaborative, and Skillz. ThredUp, an online fashion resale platform, went public on NASDAQ in 2021. WHOOP, a wearable fitness tracker, has become a significant player in the market, valued at over $3.6 billion. Attentive, an SMS marketing platform, serves over 4,000 e-commerce customers and significantly drives their revenue. NextView Ventures recently closed its fourth fund at $100 million, continuing its high-conviction, hands-on seed strategy. The firm targets the full seed spectrum, from pre-launch and pre-seed companies to those starting to scale, offering initial investments ranging from $400K to $4M​.

Nexus Venture Partners, established in 2006, is a venture capital firm headquartered in Menlo Park, California. The firm focuses on early-stage investments, typically participating in seed and Series A rounds, and is particularly active in the US and India. Nexus has over $2.6 billion in assets under management and invests in sectors such as enterprise software, digital consumer businesses, and technology-driven services. Nexus Venture Partners has an impressive portfolio that includes notable companies like Postman, Delhivery, Druva, and Unacademy. The firm has had significant exits, with companies like Clover Health, Delhivery, and Housing.com achieving substantial growth and market impact. Nexus's investment strategy emphasizes strong partnerships with founders, providing them with extensive support throughout their entrepreneurial journey. The team at Nexus comprises experienced professionals, including co-founders Suvir Sujan, Naren Gupta, and Sandeep Singhal, who bring deep industry expertise and strategic insights to their investments. Nexus Venture Partners continues to be a key player in the venture capital landscape, fostering innovation and scaling successful companies across its target markets​.

NFX, founded in 2015 and headquartered in San Francisco, is a venture capital firm that specializes in early-stage investments. The firm is renowned for its focus on network effects, which it believes are crucial for building market-transforming companies. NFX invests in a diverse range of sectors, including AI, biotech, fintech, gaming, enterprise software, marketplaces, and crypto, with a particular focus on Silicon Valley and Israel. Notable investments by NFX include companies like DoorDash, Lyft, Patreon, and Houseparty. The firm has made a total of 577 investments and has seen significant exits such as Similarweb and CircleUp. NFX's unique approach involves deeply understanding and leveraging network effects, which it views as essential for startups to compete effectively in today's market​​. The firm was co-founded by James Currier, Pete Flint, Gigi Levy-Weiss, and Stan Chudnovsky, who bring extensive entrepreneurial and investment experience. NFX supports its portfolio companies through The Guild, an active community of over 200 founders who share KPIs, insights, and access to foster mutual growth and success​. NFX aims to transform how true innovators are funded, providing not just capital but also strategic guidance to help startups build sustainable and disruptive businesses​.

ND Capital, formerly known as NanoDimension, is a venture capital firm established in 2002, headquartered in Woodside, California. The firm focuses on investing in disruptive technologies across the life sciences, physical sciences, and data sciences sectors. Their core belief is that significant breakthroughs will arise from the convergence of these scientific disciplines. The firm is led by founder and CEO Aymeric Sallin, who has been pivotal in steering the company towards successful investments. ND Capital supports early to mid-stage companies, particularly those developing innovative and market-disruptive technologies. Their investment strategy targets companies at the forefront of scientific advancements that hold the potential to create substantial impact. ND Capital's diverse portfolio includes investments in companies like Natron Energy, Tarveda Therapeutics, Selecta Biosciences, and SQZ Biotech. The firm has a strong track record with numerous successful exits, such as the acquisition of Serotiny by Johnson & Johnson and Icosavax's IPO. The team at ND Capital consists of experienced professionals with deep expertise in various scientific and industrial fields. This includes Senior Partner Patrick Aebischer, who has extensive experience in biotechnology and academic leadership, and Partner Eric Moessinger, who focuses on life sciences investments. ND Capital's mission is to back visionary founders and innovative startups that push the boundaries of science and technology, driving forward transformative solutions that address global challenges..

Nimble Ventures, founded in 2012, is a venture capital firm based in San Francisco, California. The firm focuses on early-stage investments, primarily targeting sectors such as technology, healthcare, biotech, fintech, consumer tech, and blockchain. Nimble Ventures invests globally, with notable investments in companies based in the United States and Israel. Prominent companies in their portfolio include Umbra, a developer of SAR micro-satellites for imagery services, and Terradepth, which provides data collection technology for marine tracking systems. Both companies have shown significant growth and innovation within their respective fields. Nimble Ventures typically invests in Seed and Series A stages, supporting startups with high growth potential and innovative solutions. The firm's investment strategy emphasizes identifying and nurturing early-stage companies that have the potential to transform industries through cutting-edge technology and novel approaches. For startups looking to engage with Nimble Ventures, it is important to demonstrate strong technological capabilities and a clear path to market leadership. The firm values innovative solutions that address substantial market needs and have the potential for significant impact. Key team members include John Burbank, a notable investor with a background in managing substantial venture funds, and Nathan Mee, who brings extensive experience in portfolio management and venture capital investments​.

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.

Nissay Capital, a venture capital firm based in Tokyo and wholly owned by Nippon Life Insurance Company, has a rich history of investments across various stages and sectors. With over 1,200 unlisted companies and 226 IPOs since its inception in 1991, the firm is a significant player in Japan's venture capital landscape. Notable investments include Heartseed, a biotech company, SkyDisc, and LaFabric. They focus on early to growth-stage businesses, with investments ranging from $4M to $740M. Nissay Capital's strategy emphasizes leveraging the vast network of Nippon Life Insurance to support portfolio companies, providing extensive guidance on management strategies and capital policies. They prefer investing in innovative startups that align with their long-term vision of contributing to society, particularly in technology and healthcare sectors. The firm typically co-invests with other major players like Mitsubishi UFJ Capital and CyberAgent Capital, fostering a collaborative investment environment. Key team members include Eiji Arima, the President and CEO, who plays a pivotal role in steering the firm's strategic direction. Nissay Capital prefers entrepreneurs to approach them through well-researched pitches that clearly articulate the market opportunity and technological innovation. Active and involved, they are seen as a hands-on investor committed to the growth and success of their investees

Noetic Fund is a Toronto-based venture capital firm launched in 2020, specializing in early-stage investments within the healthcare, psychedelic medicine, and biotech sectors. The fund focuses on emerging therapies and technologies aimed at improving mental health, addressing central nervous system disorders, and offering innovative solutions to global healthcare challenges. Noetic is particularly involved in the burgeoning field of psychedelic-based therapeutics, where they support companies working on treatments for conditions such as depression, PTSD, and substance use disorders. With its first fund, Noetic made around 20 investments, including notable companies like COMPASS Pathways, MindMed, and Cybin, all leaders in the psychedelic medicine space. They’ve continued to expand with the launch of Noetic Fund II, aiming to raise $200 million to further invest in groundbreaking therapies. Their strategy includes a long-term focus on companies developing new drug discoveries, digital health solutions, and medical devices that address unmet needs in mental and physical health. Noetic’s leadership includes seasoned venture capitalists and experts in life sciences, positioning the firm to capitalize on the growing acceptance and scientific validation of psychedelic treatments. They collaborate closely with portfolio companies, leveraging their expertise to foster sustainable growth and innovation.

NGP Capital, founded in 2005, is a venture capital firm based in Palo Alto, California. The firm has a significant global presence with offices in Berlin, Helsinki, and Geneva, and focuses on early growth investments in B2B sectors such as cybersecurity, industrial technology, deep tech, robotics, supply chain, and data infrastructure. NGP Capital typically invests $10-15 million in the first round, aiming for a 10-15% ownership stake and an active role in their portfolio companies. The firm manages over $1.6 billion in assets and uses a proprietary AI-powered platform, "Q," to identify and evaluate investment opportunities globally. This system scans and ranks more than 2 million companies, helping NGP make data-driven investment decisions. NGP Capital has invested in more than 100 companies, with notable exits including UC Mobile, acquired by Alibaba for $3.8 billion, and Ganji, acquired by 58.com for $3.6 billion. Other significant portfolio companies include PubMatic, Deliveroo, and Moovit. Their investments are geographically diverse, with 27% in Europe, 38% in the US, and 35% in Asia. The firm continues to leverage its partnership with Nokia, focusing on strategic investments that align with Nokia's innovation framework around 5G and related technologies. This partnership allows NGP Capital to combine financial discipline with technological insights, driving growth and strategic value in their portfolio.

Nomad Ventures is an early-stage VC firm based in Los Angeles, with a strong focus on high-growth, network-effect businesses. Their sector-agnostic approach includes fintech, consumer tech, vertical SaaS, and marketplaces, backing startups that drive new ways for people to earn money online. With notable investments in companies like Cameo and Wheels, Nomad Ventures has a track record of identifying disruptive, scalable business models. The fund primarily targets pre-seed and seed-stage investments, aiming to partner with founders who exhibit grit and a bold vision for the future. They seek startups with operational intensity and scalable distribution advantages. While geographically anchored in the U.S., particularly cities like Los Angeles, New York, Austin, and Miami, they are open to the growing decentralization of startup ecosystems across the country. Led by Chris Taylor, James Mumma, and Marco McCottry—all experienced operators who played key roles at Uber, Bird, and Opendoor—the team brings hands-on expertise and operational guidance to their portfolio companies. They actively co-invest with top-tier VCs like Andreessen Horowitz, often helping lead rounds with average check sizes ranging from $250K to $1M. Nomad is known for being approachable and looking for founders who build defensible businesses with strong marketplace dynamics. Nomad Ventures has raised over $100M and frequently scouts startups through industry relationships and tech scene connections, with a preference for companies demonstrating early, clear traction.